Treatment and outcomes of patients with HR+/HER2− early breast cancer in a real-world setting in Germany. Real-world data on HR+/HER2− EBC: a German registry analysis.

10. Februar 2026

Däßler KU, Petersen V, Zahn MO, Fakhouri W, Korfel A, Emde A, Rößler T, Kruggel L, Tech S, Jänicke M, Gratzke K.

Cancer Treatment and Research Communications. Januar 2026;101122.
Abstract